Neurology
-
To report the clinical features of myasthenia gravis (MG) induced by treatment with immune checkpoint inhibitors using 2-year safety databases based on postmarketing surveys in Japan. ⋯ The prompt and correct recognition of MG following treatment with immune checkpoint inhibitors in patients with cancer is important.